Daré Bioscience, Inc.

DARE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$4-$30-$31-$39
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$3$2$2
Change in WC$6-$10$11$9
Other Non-Cash$1-$1-$0-$0
Operating Cash Flow$5-$39-$18-$29
Investing Activities
PP&E Inv.-$1-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$1-$0-$0
Financing Activities
Debt Repay.-$0$0$0$0
Stock Issued$0$9$1$75
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$6$0$1
Financing Cash Flow$0$16$1$76
Forex Effect-$0-$0-$0-$0
Net Chg. in Cash$5-$24-$17$47
Supplemental Information
Beg. Cash$11$35$52$5
End Cash$16$11$35$52
Free Cash Flow$5-$39-$18-$29